Alla Patlis - Aug 25, 2021 Form 3 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Interim Chief Financial Officer Exhibit 24-Power of Attorney
Signature
/s/ Alla Patlis
Stock symbol
BCLI
Transactions as of
Aug 25, 2021
Transactions value $
$0
Form type
3
Date filed
9/2/2021, 04:01 PM
Next filing
Mar 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCLI Option (Right to Buy) Aug 25, 2021 Common Stock 4K $2.70 Direct F1
holding BCLI Option (Right to Buy) Aug 25, 2021 Common Stock 9.6K $9.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.
F2 This option will vest 25% per year beginning on October 22, 2021, and shall be fully vested on October 22, 2024.

Remarks:

Interim Chief Financial Officer Exhibit 24-Power of Attorney